Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker for Creatine Deficiency Syndromes. An International, Multicenter, Epidemiological Study.

NCT02934854 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT02934854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02934854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker for Creatine Deficiency Syndromes. An International, Multicenter, Epidemiological Study.
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Withdrawn
Start date
August 20, 2018
Completion date
February 28, 2021
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral disorder, developmental delay, intellectual disability, intractable epilepsy, movement disorder